[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

AVIR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 17.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $537,929.91

Atea Pharmaceuticals Insider Trading History Chart

Atea Pharmaceuticals Share Price & Price History

^$3.22

▼ -0.09 (-2.72%)

As of 11/15/2024 01:00 AM ET

Days: 30 | 90 | 365

[Urgent] Starlink Set For The Largest IPO In History?

From Paradigm Press | Ad

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.

Click here now for the urgent details on this hidden play.

Atea Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/19/2024	Jean-Pierre Sommadossi	CEO	Sell	1,841	$4.00	$7,364.00	5,866,025
9/17/2024	Jean-Pierre Sommadossi	CEO	Sell	33,941	$4.05	$137,461.05	5,890,053
6/20/2024	Bruce Polsky	Director	Sell	17,544	$3.49	$61,228.56	65,606
6/5/2024	Jean-Pierre Sommadossi	CEO	Sell	1,006	$4.00	$4,024.00	5,923,994
2/1/2024	Andrea Corcoran	Insider	Sell	15,843	$3.84	$60,837.12	670,208
2/1/2024	Jean-Pierre Sommadossi	CEO	Sell	56,910	$3.85	$219,103.50	116,557
2/1/2024	Wayne Foster	CAO	Sell	12,477	$3.84	$47,911.68	20,857
11/14/2022	Franklin M Berger	Director	Sell	16,166	$5.16	$83,416.56	778,353
11/11/2022	Franklin M Berger	Director	Sell	25,500	$5.15	$131,325.00	794,519
12/20/2021	Polly A. Murphy	Director	Buy	12,000	$8.57	$102,840.00

War on Elon Escalates…

From Porter & Company | Ad

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

SEC Filings (Institutional Ownership Changes) for Atea Pharmaceuticals (NASDAQ:AVIR)

86.67% of Atea Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Atea Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	1,924,773	$6.45M	0.0%	-4.2%	2.279%
11/15/2024	Barclays PLC	177,077	$0.59M	0.0%	+74.5%	0.210%
11/15/2024	Zacks Investment Management	23,940	$80K	0.0%	N/A	0.028%
11/15/2024	Wellington Management Group LLP	221,562	$0.74M	0.0%	-13.2%	0.262%
11/15/2024	State Street Corp	1,733,486	$5.81M	0.0%	+0.7%	2.052%
11/15/2024	Jacobs Levy Equity Management Inc.	509,471	$1.71M	0.0%	-9.8%	0.603%
11/14/2024	Verition Fund Management LLC	56,909	$0.19M	0.0%	-13.7%	0.067%
11/13/2024	FMR LLC	6,618,297	$22.17M	0.0%	+2.8%	7.836%
11/13/2024	Dynamic Technology Lab Private Ltd	11,178	$37K	0.0%	N/A	0.013%
11/12/2024	Charles Schwab Investment Management Inc.	650,157	$2.18M	0.0%	+8.5%	0.770%
11/9/2024	Intech Investment Management LLC	10,711	$36K	0.0%	N/A	0.013%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	44,157	$0.15M	0.0%	N/A	0.052%
11/5/2024	BML Capital Management LLC	6,650,000	$22.28M	13.1%	+4.3%	7.877%
10/25/2024	China Universal Asset Management Co. Ltd.	16,237	$54K	0.0%	+64.1%	0.019%
10/3/2024	SG Americas Securities LLC	30,612	$0.10M	0.0%	+117.9%	0.036%
9/16/2024	Cubist Systematic Strategies LLC	34,045	$0.11M	0.0%	-63.8%	0.040%
8/16/2024	Almitas Capital LLC	1,290,187	$4.27M	1.8%	N/A	1.532%
8/15/2024	The Manufacturers Life Insurance Company	34,886	$0.12M	0.0%	+14.2%	0.041%
8/14/2024	Cubist Systematic Strategies LLC	34,045	$0.11M	0.0%	-63.8%	0.040%
8/14/2024	Marshall Wace LLP	182,326	$0.60M	0.0%	N/A	0.216%
8/14/2024	ProShare Advisors LLC	15,466	$51K	0.0%	-21.4%	0.018%
8/12/2024	Hsbc Holdings PLC	158,109	$0.52M	0.0%	-7.7%	0.188%
8/9/2024	Renaissance Technologies LLC	1,141,500	$3.78M	0.0%	+1.6%	1.355%
8/9/2024	Dimensional Fund Advisors LP	594,360	$1.97M	0.0%	+55.2%	0.706%
8/8/2024	American Century Companies Inc.	125,169	$0.41M	0.0%	+14.6%	0.149%
8/6/2024	Acadian Asset Management LLC	934,505	$3.09M	0.0%	-2.9%	1.110%
8/1/2024	Rhumbline Advisers	137,598	$0.46M	0.0%	-3.0%	0.163%
7/29/2024	Principal Financial Group Inc.	11,425	$38K	0.0%	-55.0%	0.014%
7/26/2024	Bank of New York Mellon Corp	266,184	$0.88M	0.0%	+11.1%	0.316%
7/12/2024	SG Americas Securities LLC	14,051	$47K	0.0%	-50.1%	0.017%
5/17/2024	Tidal Investments LLC	21,472	$87K	0.0%	N/A	0.025%
5/16/2024	California State Teachers Retirement System	7,707	$31K	0.0%	-38.9%	0.009%
5/16/2024	Jacobs Levy Equity Management Inc.	672,984	$2.72M	0.0%	+22.2%	0.799%
5/15/2024	Public Employees Retirement System of Ohio	61,033	$0.25M	0.0%	+238.8%	0.072%
5/15/2024	Price T Rowe Associates Inc. MD	67,137	$0.27M	0.0%	+21.7%	0.080%
5/10/2024	Vanguard Group Inc.	4,722,522	$19.08M	0.0%	+2.7%	5.607%
5/7/2024	SG Americas Securities LLC	28,140	$0.11M	0.0%	-33.8%	0.033%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	30,465	$0.12M	0.0%	N/A	0.036%
4/29/2024	China Universal Asset Management Co. Ltd.	16,179	$65K	0.0%	+67.6%	0.019%
4/23/2024	BML Capital Management LLC	5,536,710	$22.37M	14.7%	+1.4%	6.578%
2/20/2024	Sunpointe LLC	11,943	$36K	0.0%	N/A	0.014%
2/13/2024	Stonepine Capital Management LLC	839,514	$2.56M	1.1%	-51.2%	1.006%
2/13/2024	Tower Research Capital LLC TRC	30,340	$93K	0.0%	+128.2%	0.036%
2/12/2024	RPO LLC	12,947	$39K	0.1%	N/A	0.016%
2/6/2024	New York Life Investment Management LLC	103,087	$0.31M	0.0%	-3.0%	0.124%
2/2/2024	Marquette Asset Management LLC	47,166	$0.14M	0.0%	+89.7%	0.057%
2/2/2024	Acuitas Investments LLC	171,098	$0.52M	0.3%	+38.6%	0.205%
1/31/2024	Federated Hermes Inc.	595,692	$1.82M	0.0%	-2.2%	0.714%
1/30/2024	BML Capital Management LLC	5,462,079	$16.66M	12.6%	+13.8%	6.546%
1/24/2024	China Universal Asset Management Co. Ltd.	9,653	$29K	0.0%	+351.3%	0.012%
1/12/2024	SG Americas Securities LLC	42,521	$0.13M	0.0%	+23.3%	0.051%
12/18/2023	Gladius Capital Management LP	8,581	$26K	0.0%	+98.2%	0.010%
11/15/2023	GSA Capital Partners LLP	278,286	$0.84M	0.1%	+41.9%	0.334%
11/15/2023	Sectoral Asset Management Inc.	600,461	$1.80M	0.4%	+19.7%	0.720%
11/14/2023	Newtyn Management LLC	400,000	$1.20M	0.3%	+348.4%	0.479%
11/14/2023	Stonepine Capital Management LLC	1,720,000	$5.16M	1.7%	+128.7%	2.061%
11/13/2023	Federated Hermes Inc.	608,786	$1.83M	0.0%	-0.8%	0.730%
11/13/2023	Acadian Asset Management LLC	987,916	$2.96M	0.0%	-0.8%	1.184%
11/13/2023	FMR LLC	6,452,550	$19.36M	0.0%	-24.1%	7.733%
11/8/2023	New York Life Investment Management LLC	106,281	$0.32M	0.0%	-13.6%	0.127%
11/8/2023	Pinnacle Wealth Planning Services Inc.	16,185	$49K	0.0%	N/A	0.019%
11/7/2023	CM Management LLC	275,000	$0.83M	0.9%	+10.0%	0.330%
11/7/2023	Barclays PLC	25,619	$77K	0.0%	+67.8%	0.031%
11/2/2023	Principal Financial Group Inc.	30,392	$91K	0.0%	+17.7%	0.036%
10/23/2023	BML Capital Management LLC	4,800,000	$14.40M	13.2%	+114.6%	5.755%
10/13/2023	SG Americas Securities LLC	34,497	$0.10M	0.0%	N/A	0.041%
10/11/2023	Vontobel Holding Ltd.	600,461	$1.80M	0.0%	+19.7%	0.720%
10/10/2023	Gladius Capital Management LP	8,581	$26K	0.0%	+98.2%	0.010%
9/21/2023	Barclays PLC	15,271	$57K	0.0%	-60.6%	0.018%
8/16/2023	Stonepine Capital Management LLC	752,088	$2.81M	1.0%	+9.9%	0.902%
8/14/2023	Anson Funds Management LP	50,000	$0.19M	0.0%	N/A	0.060%
8/14/2023	Shay Capital LLC	34,635	$0.13M	0.0%	N/A	0.042%
8/14/2023	Prelude Capital Management LLC	24,078	$90K	0.0%	-15.5%	0.029%
8/14/2023	Graham Capital Management L.P.	10,113	$38K	0.0%	N/A	0.012%
8/11/2023	Stonepine Capital Management LLC	752,088	$2.81M	1.1%	+9.9%	0.902%
8/11/2023	Sectoral Asset Management Inc.	501,537	$1.88M	0.3%	+31.7%	0.601%
8/7/2023	Principal Financial Group Inc.	25,818	$97K	0.0%	+16.3%	0.031%
8/7/2023	Acadian Asset Management LLC	996,275	$3.72M	0.0%	-10.3%	1.195%
8/7/2023	New York Life Investment Management LLC	123,025	$0.46M	0.0%	-15.4%	0.148%
8/4/2023	CM Management LLC	250,000	$0.94M	0.9%	-23.1%	0.300%
7/31/2023	Strs Ohio	100,700	$0.38M	0.0%	+5.8%	0.121%
7/24/2023	Vontobel Holding Ltd.	501,537	$1.88M	0.0%	+31.7%	0.601%
7/24/2023	BML Capital Management LLC	2,236,239	$8.36M	7.5%	N/A	2.681%
7/7/2023	Auour Investments LLC	177,000	$0.66M	0.3%	N/A	0.212%
6/1/2023	Prelude Capital Management LLC	28,500	$95K	0.0%	N/A	0.034%
5/15/2023	Stonepine Capital Management LLC	684,508	$2.29M	0.8%	N/A	0.821%
5/12/2023	Sectoral Asset Management Inc.	380,850	$1.28M	0.2%	+35.3%	0.457%
5/12/2023	Martingale Asset Management L P	40,100	$0.13M	0.0%	-81.5%	0.048%
5/11/2023	Acadian Asset Management LLC	1,110,715	$3.72M	0.0%	+27.9%	1.332%
5/8/2023	New York Life Investment Management LLC	145,359	$0.49M	0.0%	+85.0%	0.174%
5/8/2023	CM Management LLC	325,000	$1.09M	1.3%	+18.2%	0.390%
5/8/2023	Federated Hermes Inc.	2,039,056	$6.83M	0.0%	-33.8%	2.445%
5/3/2023	Integrated Wealth Concepts LLC	10,140	$34K	0.0%	N/A	0.012%
5/1/2023	Marquette Asset Management LLC	24,865	$83K	0.0%	N/A	0.030%
5/1/2023	CM Wealth Advisors LLC	19,400	$64K	0.0%	N/A	0.023%
4/28/2023	SG Americas Securities LLC	31,179	$0.10M	0.0%	-20.1%	0.037%
4/27/2023	Strs Ohio	95,200	$0.32M	0.0%	-25.6%	0.114%
4/21/2023	Congress Asset Management Co. MA	197,312	$0.66M	0.0%	+10.9%	0.237%
4/18/2023	ETF Managers Group LLC	26,460	$89K	0.0%	+27.4%	0.032%
4/13/2023	Allspring Global Investments Holdings LLC	23,716	$79K	0.0%	+619.8%	0.028%

Data available starting January 2016

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antiviral therapeutics for patients with viral infections. Its lead product candidate is AT-527, an oral antiviral candidate that is in Phase 3 SUNRISE-3 clinical trial for the treatment of patients with COVID-19. The company also develops bemnifosbuvir in combination with ruzasvir, which is in Phase 2 clinical trial, for the treatment of hepatitis C virus (HCV); and a protease inhibitor for the treatment of COVID-19. It has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of Ruzasvir, an NS5A inhibitor, for the treatment of HCV. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $3.22

$3.18

$3.35

50 Day Range

MA: $3.51

$3.22

$4.02

52 Week Range

Now: $3.22

$2.77

$4.60

Volume

313,823 shs

Average Volume

167,651 shs

Market Capitalization

$271.96 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.17

Who are the company insiders with the largest holdings of Atea Pharmaceuticals?: Atea Pharmaceuticals' top insider investors include:
Jean-Pierre Sommadossi (CEO)
Andrea Corcoran (Insider)
Bruce Polsky (Director)
Wayne Foster (CAO)
Learn More about top insider investors at Atea Pharmaceuticals.
Who are the major institutional investors of Atea Pharmaceuticals?: Atea Pharmaceuticals' top institutional investors include:
BML Capital Management LLC — 7.88%
FMR LLC — 7.84%
Geode Capital Management LLC — 2.28%
State Street Corp — 2.05%
Charles Schwab Investment Management Inc. — 0.77%
Jacobs Levy Equity Management Inc. — 0.60%
Learn More about top institutional investors of Atea Pharmaceuticals stock.
Which institutional investors are selling Atea Pharmaceuticals stock?: In the last quarter, AVIR stock was sold by these institutional investors:
Geode Capital Management LLC
Jacobs Levy Equity Management Inc.
Wellington Management Group LLP
Verition Fund Management LLC
In the last year, company insiders that have sold Atea Pharmaceuticals company stock include:
Jean-Pierre Sommadossi (CEO)
Andrea Corcoran (Insider)
Bruce Polsky (Director)
Wayne Foster (CAO)
Learn More investors selling Atea Pharmaceuticals stock.
Which institutional investors are buying Atea Pharmaceuticals stock?: In the last quarter, AVIR stock was acquired by institutional investors including:
BML Capital Management LLC
FMR LLC
Barclays PLC
Charles Schwab Investment Management Inc.
Connor Clark & Lunn Investment Management Ltd.
Zacks Investment Management
SG Americas Securities LLC
State Street Corp